# CLSTN2

## Overview
The CLSTN2 gene encodes the protein calsyntenin-2, a type I transmembrane protein that is part of the calsyntenin family, which also includes calsyntenin-1 and calsyntenin-3. Calsyntenin-2 is predominantly expressed in the brain and is involved in synaptic adhesion and intracellular transport, playing a crucial role in neuronal function and development (Mori2022Loss; de2017Calsyntenins). Unlike its paralogs, calsyntenin-2 does not exhibit synaptogenic activity but is essential for synaptic signaling and plasticity, particularly in regions such as the hippocampus (Lipina2015Cognitive). The protein is associated with cognitive functions, including memory processes, and has been implicated in neuropsychiatric disorders such as autism spectrum disorder and schizophrenia, highlighting its significance in maintaining synaptic and cognitive health (Rozhkova2023Alterations; de2017Calsyntenins).

## Structure
Calsyntenin-2 (CLSTN2) is a type I transmembrane protein that is part of the calsyntenin family, which includes CLSTN1 and CLSTN3. The primary structure of CLSTN2 features a signal peptide, cadherin-like domains, and a transmembrane region (Mori2022Loss; de2017Calsyntenins). The protein contains two N-terminal cadherin domains, an LNS domain, and a short cytoplasmic tail (Liu2021Calsyntenin3). These domains are involved in synaptic adhesion and intracellular transport, although CLSTN2 does not exhibit synaptogenic activity like its paralogs (Lipina2015Cognitive).

The secondary structure of CLSTN2 likely includes alpha-helices and beta-sheets, common in proteins with cadherin-like domains. The tertiary structure is stabilized by disulfide bonds, which are typical in maintaining the structural integrity of cadherin domains. Post-translational modifications such as glycosylation may occur, contributing to the protein's stability and function (de2017Calsyntenins).

CLSTN2 is expressed in a brain-specific manner, with high levels in certain neurons, including hippocampal CA2-CA3 pyramidal neurons and cerebellar Purkinje cells (Lipina2015Cognitive). Despite its structural similarities to other calsyntenins, CLSTN2 has distinct roles in cognitive function and synaptic development (Lipina2015Cognitive).

## Function
Calsyntenin-2 (CLSTN2) is a synaptic protein that plays a significant role in neuronal function and development. It is predominantly expressed in the brain, particularly in GABAergic interneurons and certain regions of the hippocampus, such as the CA1-CA3 areas, where it contributes to synaptic signaling and plasticity (Ranneva2017Features; Hintsch2002The). CLSTN2 is involved in intracellular transport, acting as a cargo-docking protein that facilitates vesicular transport along axons, which is crucial for synapse formation and maintenance (de2017Calsyntenins). 

The protein is part of the cadherin superfamily and is associated with calcium-binding and cell adhesion processes, linking extracellular cell adhesion events to intracellular calcium signaling (Hintsch2002The). This function is essential for synaptic plasticity, which underlies learning and memory processes. In humans, CLSTN2 has been linked to cognitive functions, including enhanced episodic memory, suggesting its involvement in memory-related cognitive processes (de2017Calsyntenins). 

CLSTN2's expression in the postsynaptic membrane of excitatory synapses indicates its role in modulating excitatory and inhibitory balance in neuronal circuits, which is vital for proper cognitive and behavioral functions (Ranneva2017Features; Hintsch2002The).

## Clinical Significance
Mutations and alterations in the CLSTN2 gene have been implicated in several neuropsychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia. In ASD, a deletion in the second intron of the CLSTN2 gene has been identified in some patients, suggesting a potential genetic risk factor. CLSTN2 knockout (KO) mice, which model ASD, exhibit behaviors such as impaired social motivation, recognition, and communication, as well as hyperactivity and stereotypy, which align with core ASD symptoms (Rozhkova2023Alterations; Ranneva2017Features). These mice also show an imbalance in synaptic transmission due to a reduction in inhibitory interneurons, particularly in the hippocampus, which is characteristic of some ASD patients (Rozhkova2022Neuronal).

In schizophrenia, the loss of CLSTN2, along with other calsyntenin paralogs, leads to a decrease in parvalbumin-positive inhibitory neurons, a typical endophenotype observed in schizophrenia patients. This reduction is associated with hypersensitivity to stress and altered stress responses, which are linked to the hypothalamic-pituitary-adrenal axis (Mori2022Loss). These findings suggest that CLSTN2 plays a role in maintaining interneuron stability and synaptic function, with its disruption contributing to the pathogenesis of these disorders.

## Interactions
CLSTN2 (calsyntenin 2) is known to participate in several important protein interactions that are crucial for its role in synaptic function and neuronal development. One of the primary interactions of CLSTN2 is with kinesin-1, a motor protein that plays a significant role in axonal transport. This interaction facilitates the movement of synaptic vesicles and other cargo along the axon, which is essential for maintaining synaptic function and plasticity. Through its interaction with kinesin-1, CLSTN2 contributes to the efficient trafficking of synaptic vesicles, which is vital for neurotransmitter release and synaptic signaling.

CLSTN2 may also interact with other synaptic proteins, although specific partners are not detailed in the provided context. These interactions likely influence synaptic plasticity, a process that underlies learning and memory by modulating the strength and efficacy of synaptic connections. The involvement of CLSTN2 in these processes underscores its importance in the nervous system, particularly in the context of synaptic development and function. The precise mechanisms and additional interaction partners of CLSTN2 remain areas of active research, highlighting the complexity of its role in neuronal physiology.


## References


[1. (Rozhkova2023Alterations) I. N. Rozhkova, S. V. Okotrub, E. Yu. Brusentsev, K. E. Uldanova, E. A. Chuyko, V. A. Naprimerov, T. V. Lipina, T. G. Amstislavskaya, and S. Ya. Amstislavsky. Alterations in the social-conditioned place preference and density of dopaminergic neurons in the ventral tegmental area in clsnt2-ko mice. Vavilov Journal of Genetics and Breeding, 27(2):177–184, April 2023. URL: http://dx.doi.org/10.18699/vjgb-23-14, doi:10.18699/vjgb-23-14. This article has 2 citations.](https://doi.org/10.18699/vjgb-23-14)

2. (Liu2021Calsyntenin3) Calsyntenin-3, an atypical cadherin, suppresses inhibitory basket- and stellate-cell synapses but boosts excitatory parallel-fiber synapses in cerebellum. This article has 0 citations.

[3. (de2017Calsyntenins) Gemma de Ramon Francàs, Tobias Alther, and Esther T. Stoeckli. Calsyntenins are expressed in a dynamic and partially overlapping manner during neural development. Frontiers in Neuroanatomy, August 2017. URL: http://dx.doi.org/10.3389/fnana.2017.00076, doi:10.3389/fnana.2017.00076. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnana.2017.00076)

[4. (Rozhkova2022Neuronal) I. N. Rozhkova, S. V. Okotrub, E. Yu. Brusentsev, E. E. Uldanova, E. А. Chuyko, T. V. Lipina, T. G. Amstislavskaya, and S. Ya. Amstislavsky. Neuronal density in the brain cortex and hippocampus in clsnt2-ko mouse strain modeling autistic spectrum disorder. Vavilov Journal of Genetics and Breeding, 26(4):365–370, July 2022. URL: http://dx.doi.org/10.18699/vjgb-22-44, doi:10.18699/vjgb-22-44. This article has 0 citations.](https://doi.org/10.18699/vjgb-22-44)

[5. (Ranneva2017Features) S.V. Ranneva, K.S. Pavlov, A.V. Gromova, T.G. Amstislavskaya, and T.V. Lipina. Features of emotional and social behavioral phenotypes of calsyntenin2 knockout mice. Behavioural Brain Research, 332:343–354, August 2017. URL: http://dx.doi.org/10.1016/j.bbr.2017.06.029, doi:10.1016/j.bbr.2017.06.029. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbr.2017.06.029)

[6. (Mori2022Loss) Keita Mori, Michinori Koebis, Kazuki Nakao, Shizuka Kobayashi, Yuji Kiyama, Masahiko Watanabe, Toshiya Manabe, Yuichi Iino, and Atsu Aiba. Loss of calsyntenin paralogs disrupts interneuron stability and mouse behavior. Molecular Brain, March 2022. URL: http://dx.doi.org/10.1186/s13041-022-00909-8, doi:10.1186/s13041-022-00909-8. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13041-022-00909-8)

[7. (Lipina2015Cognitive) Tatiana V Lipina, Tuhina Prasad, Daisaku Yokomaku, Lin Luo, Steven A Connor, Hiroshi Kawabe, Yu Tian Wang, Nils Brose, John C Roder, and Ann Marie Craig. Cognitive deficits in calsyntenin-2-deficient mice associated with reduced gabaergic transmission. Neuropsychopharmacology, 41(3):802–810, July 2015. URL: http://dx.doi.org/10.1038/npp.2015.206, doi:10.1038/npp.2015.206. This article has 47 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/npp.2015.206)

[8. (Hintsch2002The) G Hintsch. The calsyntenins—a family of postsynaptic membrane proteins with distinct neuronal expression patterns. Molecular and Cellular Neuroscience, 21(3):393–409, November 2002. URL: http://dx.doi.org/10.1006/mcne.2002.1181, doi:10.1006/mcne.2002.1181. This article has 108 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/mcne.2002.1181)